Pilot trials of oral betaine in participants with non-alcoholic fatty liver disease and elevated alanine aminotransferase.

求助中 10 由 kathy meow 发布于 2026/6/14 23:41:05

DOI:10.1097/hep.0000000000001477
作者：Andrew S Lim,Sheena N Cruz,Aliya Asghar Uddin,Olga Malysheva,Marie A Caudill,Cristina Alonso,Alejandro Montilla,Morten A Karsdal,Diana Julie Leeming,Alejandro E Mayorca-Guiliani,Frederik H?bjerg Svejs
文献类型：期刊论文
补充材料：只需要正文

Wolters Kluwer Ovid

Abstract：BACKGROUND/AIM Betaine, 20 grams/day for 12 months, reduced liver injury in several trials in non-alcoholic steatohepatitis (NASH). Our aim was to determine the safety and efficacy of lower

应助信息

等您来应助

上传文件

请确保您上传的文献材料真实、完整，且未作任何人为改动
文件格式pdf、docx、zip、txt。文件大小不超过50MB。
在线压缩PDF 电子书转换PDF

3小时前

Book学术机器人

2026/6/14 23:41:05 未找到该文献，机器人已退出，请等待人工下载

2026/6/14 23:41:05 Book学术AI机器人收到请求，开始寻找文献

2026/6/14 23:41:05 已向机器人发送请求

3小时前

kathy meow 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Taylor & FrancisThiosemicarbazone Schiff base ligands and their complexes with nickel, palladium and platinum show anticancer and antibacterial activities